Bio-Techne Corp. Share Price Today: Live Updates & Key Insights

Bio-Techne Corp. share price today is $51.84, up -0.21%. The stock opened at $50.6781 against the previous close of $51.59, with an intraday high of $52.135 and low of $50.6781.

Bio-Techne Corp. Share Price Chart

Bio-Techne Corp.

us-stock
To Invest in {{usstockname}}
us-stock

Bio-Techne Corp. Share Price Performance

$51.84 -0.0021(-0.21%) TECH at 23 Mar 2026 03:27 PM Biotechnology
Lowest Today 50.6781
Highest Today 52.135
Today’s Open 50.6781
Prev. Close 51.59
52 Week High 72.06
52 Week Low 45.74
Day’s Range: Low 50.6781 High 52.135
52-Week Range: Low 45.74 High 72.06
1 day return -
1 Week return +5.46
1 month return -5.91
3 month return -12.68
6 month return -2.92
1 year return -15.69
3 year return -29.07
5 year return -46.5
10 year return -

Bio-Techne Corp. Institutional Holdings

Vanguard Group Inc 11.38

BlackRock Inc 7.60

Morgan Stanley - Brokerage Accounts 4.63

State Street Corp 3.68

Wellington Management Company LLP 3.67

Geode Capital Management, LLC 3.15

Vanguard Total Stock Mkt Idx Inv 3.15

Eaton Vance Atlanta Capital SMID-Cap I 2.60

Massachusetts Financial Services Company 2.56

Vanguard 500 Index Investor 2.54

Amvescap Plc. 2.52

Maverick Capital Ltd 2.46

Vanguard Small Cap Index 2.26

T. Rowe Price Associates, Inc. 2.14

Neuberger Berman Group LLC 2.00

Select Equity Group LP 1.81

Ameriprise Financial Inc 1.80

Invesco S&P 500® Equal Weight ETF 1.79

Mairs & Power Inc 1.77

Vanguard Health Care Inv 1.69

DF Dent & Co Inc 1.66

Mackenzie Investments 1.64

William Blair Investment Management, LLC 1.53

Sumitomo Mitsui Trust Group Inc 1.51

Vanguard Explorer Inv 1.47

RGM Capital LLC 1.38

Durable Capital Partners LP 1.34

US Small-Cap Growth II Equity Comp 1.33

iShares Core S&P 500 ETF 1.28

Fidelity 500 Index 1.27

Vanguard Small Cap Growth Index Inv 1.25

State Street® SPDR® S&P 500® ETF 1.17

T. Rowe Price New Horizons 1.16

MFS Mid Cap Growth A 1.15

MFS Mid Cap Growth Equity 1.15

Neuberger Genesis Inv 1.14

American Century Heritage Inv 0.97

American Century US Opport. Mid Cap Gr 0.97

Champlain Mid Cap Fund, LLC 0.96

Mairs & Power Growth 0.93

Bio-Techne Corp. Market Status

Strong Buy: 7

Buy: 3

Hold: 5

Sell: 0

Strong Sell: 0

Bio-Techne Corp. Fundamentals

Market Cap 8054.22 M

PB Ratio 4.0067

PE Ratio 97.1321

Enterprise Value 8235.36 M

Total Assets 2557.87 M

Volume 3098548

Bio-Techne Corp. Company Financials

Annual Revenue FY25:1219635000 1219.6M, FY24:1159060000 1159.1M, FY23:1136702000 1136.7M, FY22:1105599000 1105.6M, FY21:931032000 931.0M

Annual Profit FY25:790272000 790.3M, FY24:769725000 769.7M, FY23:769815000 769.8M, FY22:756496000 756.5M, FY21:632850000 632.9M

Annual Net worth FY25:73400000 73.4M, FY24:168105000 168.1M, FY23:285263000 285.3M, FY22:272051000 272.1M, FY21:140410000 140.4M

Quarterly Revenue Q4/2025:295877000 295.9M, Q3/2025:286555000 286.6M, Q2/2025:316964000 317.0M, Q1/2025:316181000 316.2M, Q4/2024:297031000 297.0M

Quarterly Profit Q4/2025:191277000 191.3M, Q3/2025:188112000 188.1M, Q2/2025:198812000 198.8M, Q1/2025:214556000 214.6M, Q4/2024:193886000 193.9M

Quarterly Net worth Q4/2025:38009000 38.0M, Q3/2025:38185000 38.2M, Q2/2025:-17678000 -17.7M, Q1/2025:22588000 22.6M, Q4/2024:34890000 34.9M

About Bio-Techne Corp. & investment objective

Company Information Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.

Organisation Biotechnology

Employees 3100

Industry Biotechnology

CEO Mr. Kim Kelderman

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Bio-Techne Corp. FAQs

What is the share price of Bio-Techne Corp. today?

The current share price of Bio-Techne Corp. is $51.84.

Can I buy Bio-Techne Corp. shares in India?

Yes, Indian investors can buy Bio-Techne Corp. shares by opening an international trading and demat account with Motilal Oswal.

How to buy Bio-Techne Corp. shares in India?

You can easily invest in Bio-Techne Corp. shares from India by:

Can I buy fractional shares of Bio-Techne Corp.?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Bio-Techne Corp.?

Bio-Techne Corp. has a market cap of $8054.22 M.

In which sector does Bio-Techne Corp. belong?

Bio-Techne Corp. operates in the Biotechnology sector.

What documents are required to invest in Bio-Techne Corp. stocks?

To invest, you typically need:

What is the PE and PB ratio of Bio-Techne Corp.?

The PE ratio of Bio-Techne Corp. is 97.13 and the PB ratio is 4.01.